SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-10-056890
Filing Date
2010-11-08
Accepted
2010-11-08 16:06:25
Documents
12
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a10-17237_110q.htm 10-Q 1190030
2 EX-10.1 a10-17237_1ex10d1.htm EX-10.1 17427
3 EX-10.2 a10-17237_1ex10d2.htm EX-10.2 221113
4 EX-31.1 a10-17237_1ex31d1.htm EX-31.1 12591
5 EX-31.2 a10-17237_1ex31d2.htm EX-31.2 12535
6 EX-32.1 a10-17237_1ex32d1.htm EX-32.1 6430
  Complete submission text file 0001104659-10-056890.txt   4863848

Data Files

Seq Description Document Type Size
7 EX-101.INS amln-20100930.xml EX-101.INS 710215
8 EX-101.SCH amln-20100930.xsd EX-101.SCH 20823
9 EX-101.CAL amln-20100930_cal.xml EX-101.CAL 40196
10 EX-101.LAB amln-20100930_lab.xml EX-101.LAB 213726
11 EX-101.PRE amln-20100930_pre.xml EX-101.PRE 108289
12 EX-101.DEF amln-20100930_def.xml EX-101.DEF 68772
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19700 | Film No.: 101172466
SIC: 2834 Pharmaceutical Preparations